Weekly Digest – Feb 2024 Weekly Digest – Feb 2024 09 Feb 2024: Bristol Myers Squibb finalizes agreement with SystImmune for BL-B01D1 in ADC Bristol Myers Squibb completes Global Strategic License and Collaboration Agreement with SystImmune for BL-B01D1, a potentially […]
Weekly Digest – Feb 2024 Weekly Digest – Feb 2024 06 Feb 2024: Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab ADC Nascent Biotech, pioneering the development of mAbs collaborates with Manhattan BioSolutions to explore antibody-drug conjugates using Nascent’s […]
Weekly Digest – Feb 2024 Weekly Digest – Feb 2024 07 Feb 2024: Samsung Biologics and LegoChem Sign ADC Partnership Agreement Samsung Biologics, a global CDMO, has signed an agreement with LegoChem Biosciences, a biotech company specializing in ADC programs […]
